Loading provider…
Loading provider…
Hematology & Oncology Physician in Santa Monica, CA
NPI: 1104850932Primary Employer
UCLA Medical Plaza
uclahealth.org
HQ Phone
Get MD Zev's Phone Numberphone_androidMobile
Get MD Zev's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2003 - 2027
NY State Medical License
2001 - 2003

American Board of Internal Medicine
Medical Oncology
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Hematology and Medical Oncology
2003 - 2006
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
Residency • Internal Medicine
2000 - 2003
Tel Aviv University Sackler
Medical School
Until 2000
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 164 | 339 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 151 | 415 |
| 3 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 123 | 501 |
| 4 | 80053Blood test, comprehensive group of blood chemicals | 123 | 447 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 84 | 84 |
Authors: Moehler, Markus, Dvorkin, Mikhail, Boku, Narikazu, Özgüroğlu, Mustafa, Ryu, Min-Hee, Muntean, Alina S, Lonardi, Sara, Nechaeva, Marina, Bragagnoli, Arinilda C, Coşkun, Hasan S, Cubillo Gracian, Antonio, Takano, Toshimi, Wong, Rachel, Safran, Howard, Vaccaro, Gina M, Wainberg, Zev A, Silver, Matthew R, Xiong, Huiling, Hong, Janet, Taieb, Julien, Bang, Yung-Jue
Journal: J Clin Oncol
Publication Date: 2020-11-16
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: PDR001, DRUG: NZV930, DRUG: KAZ954, DRUG: NIR178
Lead Sponsor: Jonsson Comprehensive Cancer Center
Collaborators: Bristol-Myers Squibb, NovoCure Ltd.
Intervention / Treatment: BIOLOGICAL: Nivolumab, PROCEDURE: Therapeutic Conventional Surgery, DRUG: Fluorouracil, DRUG: Oxaliplatin, DRUG: Irinotecan, DRUG: Leucovorin, DRUG: Irinotecan Hydrochloride, DRUG: Leucovorin Calcium
Lead Sponsor: Jonsson Comprehensive Cancer Center
Collaborators: BioMarin Pharmaceutical, Medivation, Inc., Translational Research in Oncology
Intervention / Treatment: OTHER: laboratory biomarker analysis, OTHER: pharmacological study, DRUG: temozolomide, DRUG: irinotecan hydrochloride, DRUG: PARP inhibitor BMN-673